Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

BXT-51072 in phase I clinical trials

Aug. 16, 1996

U.S. patent reinforces OraVax's UreAB development position

Aug. 16, 1996

Novopharm states intention to market generic ranitidine

Aug. 16, 1996

Glaxo Wellcome fights Novopharm attempt to market generic ranitidine

Aug. 16, 1996

Canadian researchers report GLP-2's potential as digestive disease treatment

Aug. 9, 1996

Astra reports gastrin secretion inhibitors

Aug. 9, 1996

CL-316243: Claimed as gastrointestinal disorders treatment by Glaxo Wellcome

July 26, 1996

Anti-H. pylori compound from Toyama

July 26, 1996

Thiophene and thiophene derivatives described by Sankyo as ulcer treatment

July 26, 1996

Anti-H. pylori cephem compounds described by Fujisawa

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...